On ECHEMI
Home > Drugs > Jilin Xianfeng Technical Pharmaceutical Co., Ltd.

Jilin Xianfeng Technical Pharmaceutical Co., Ltd.

  • Founded in:

    2003-01-14
  • Country:

    China China
  • Address:

    No. 9, Xianfeng Street, Nong'an County
  • Tax NO.:

    9122012274303157XG
  • Registered Funds:

    35 million yuan
  • Website:

  • Email:

Related Drugs
Daidzein Tablets
The main ingredient is daidzein.
Name Description Content CAS NO. Registered Holders
Daidzein

Dilate the coronary arteries, femoral arteries, and cerebral arteries, increase cerebral blood flow, strengthen blood circulation in the limbs, reduce blood viscosity, weaken vascular resistance, reduce cardiac oxygen consumption, improve cardiac function, enhance microcirculation, increase peripheral blood flow, change blood rheology, lower blood pressure, and improve heart rhythm

More

Dilate the coronary arteries, femoral arteries, and cerebral arteries, increase cerebral blood flow, strengthen blood circulation in the limbs, reduce blood viscosity, weaken vascular resistance, reduce cardiac oxygen consumption, improve cardiac function, enhance microcirculation, increase peripheral blood flow, change blood rheology, lower blood pressure, and improve heart rhythm

486-66-8 5
Vitamin E tablets
The main ingredient of this product is vitamin E, and its chemical name is (plusmn;)-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-benzodihydropyranol acetate.
Name Description Content CAS NO. Registered Holders
Vitamin E

It participates in some metabolic reactions in the body, can fight against the peroxidation of free radicals, delay aging, protect the skin, enhance ovarian function, and prevent habitual abortion.

More

It participates in some metabolic reactions in the body, can fight against the peroxidation of free radicals, delay aging, protect the skin, enhance ovarian function, and prevent habitual abortion.

2074-53-5 11
Daidzein Tablets
The main ingredient and chemical name of this product is: 4',7-dihydroxyisoflavone.
Name Description Content CAS NO. Registered Holders
Daidzein

Dilate the coronary arteries, femoral arteries, and cerebral arteries, increase cerebral blood flow, strengthen blood circulation in the limbs, reduce blood viscosity, weaken vascular resistance, reduce myocardial oxygen consumption, improve cardiac function, enhance microcirculation, increase peripheral blood flow, change blood rheology, lower blood pressure, and improve heart rhythm

More

Dilate the coronary arteries, femoral arteries, and cerebral arteries, increase cerebral blood flow, strengthen blood circulation in the limbs, reduce blood viscosity, weaken vascular resistance, reduce myocardial oxygen consumption, improve cardiac function, enhance microcirculation, increase peripheral blood flow, change blood rheology, lower blood pressure, and improve heart rhythm

486-66-8 5
Daidzein Tablets
The main ingredient and chemical name of this product is: 4',7-dihydroxyisoflavone.
Name Description Content CAS NO. Registered Holders
Daidzein

Dilate the coronary arteries, femoral arteries, and cerebral arteries, increase cerebral blood flow, strengthen blood circulation in the limbs, reduce blood viscosity, weaken vascular resistance, reduce myocardial oxygen consumption, improve cardiac function, enhance microcirculation, increase peripheral blood flow, change blood rheology, lower blood pressure, and improve heart rhythm

More

Dilate the coronary arteries, femoral arteries, and cerebral arteries, increase cerebral blood flow, strengthen blood circulation in the limbs, reduce blood viscosity, weaken vascular resistance, reduce myocardial oxygen consumption, improve cardiac function, enhance microcirculation, increase peripheral blood flow, change blood rheology, lower blood pressure, and improve heart rhythm

486-66-8 5
Lincomycin Hydrochloride Capsules
The main ingredient of this product is lincomycin hydrochloride.
Name Description Content CAS NO. Registered Holders
Lincomycin hydrochloride

It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as enterococci, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

More

It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as enterococci, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

859-18-7 30
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.